Warrell R P, Currie V, Kempin S, Young C
Cancer Treat Rep. 1979 Aug;63(8):1423-5.
A phase II trial of pyrazofurin, alone and in combination with trifluorothymidine, was carried out in patients with advanced non-Hodgkin's lymphoma. None of the 19 patients evaluable for response had complete or partial remissions but 14 had minor regressions. Toxicity, consisting primarily of myelosuppression and stomatitis, was of moderate severity. These studies suggest that pyrazofurin, alone or in combination with trifluorothymidine, is of limited utility in advanced non-Hodgkin's lymphoma.
对19例晚期非霍奇金淋巴瘤患者进行了嘌呤霉素单独及联合三氟胸苷的II期试验。在19例可评估疗效的患者中,无一例达到完全缓解或部分缓解,但有14例病情出现轻度缓解。毒性主要表现为骨髓抑制和口腔炎,严重程度为中度。这些研究表明,嘌呤霉素单独或联合三氟胸苷在晚期非霍奇金淋巴瘤中的应用价值有限。